Open access · CC BY-NC-SA 4.0

Outcome of Hospitalized Pneumonia Patients with and without COVID-19: A Retrospective Cohort Study

Published 2022-01-07 Issue Vol. 6 No. 1 (2022) Pages 17-23 DOI https://doi.org/10.15586/jrenhep.v6i1.132
PDF HTML XML Cite

Abstract

COVID-19 pneumonia and community-acquired pneumonia (CAP) have been associated with morbidity and mortality. The aim of this study was to evaluate the outcome of hospitalized patients with COVID-19 pneumonia versus CAP in terms of mortality. This was a retrospective cohort study conducted between pre-COVID-19 era (May 2019–November 2019) and COVID-19 era (May 2020–November 2020). The study included all adult patients with COVID-19 pneumonia (Group 1) and adult patients with CAP but are COVID-19 negative (Group 2). A total of 106 patients were included in the study, of which 56 were in the COVID-19 pneumonia group and 50 in the CAP group. Patients who developed acute kidney injury (AKI) were 60.7% (n = 34) in Group 1 and 48% (n = 24) in Group 2. Mortality occurred in 37.5% (n = 21) patients in Group 1 and 12.0% (n = 6) in Group 2 (P = 0.003). A total of 52 patients required admission to intensive care unit (ICU), of which 44.6% (n = 25) were in Group 1 and 54.0% (n = 27) in Group 2. Of the 58 patients who developed AKI, 3 (8.8%) patients in Group 1 passed away compared to none in Group 2. Moreover, 58.8% patients (n = 20) in Group 1 and 70.8% patients (n = 17) in Group 2 required ICU admission. Mortality rate in the ICU was 80.0% (n = 16) and 35.3% (n = 6) in Groups 1 and 2, respectively (P = 0.006). The overall mortality rate was higher in case of COVID-19 patients than those with CAP. In case of patients with AKI, mortality rate in the ICU was significantly higher in COVID-19 pneumonia patients compared to CAP patients.

Keywords

acute kidney injuryCOVID-19mortalitypneumonia

How to Cite

Outcome of Hospitalized Pneumonia Patients with and without COVID-19: A Retrospective Cohort Study. (2022). Journal of Renal and Hepatic Disorders, 6(1), 17-23. https://doi.org/10.15586/jrenhep.v6i1.132

References

Tsai PH, Lai WY, Lin YY, Luo YH, Lin YT, Chen HK, et al. Clinical manifestation and disease progression in COVID-19 infection. J Chin Med Assoc. 2021 Jan;84(1):3–8. 10.1097/JCMA.0000000000000463

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020 Mar;395(10229):1054–62. 10.1016/S0140-6736(20)30566-3

Green MS, Peer V, Schwartz N, Nitzan D. The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal—A comparison of age-specific and age-adjusted CFRs between seven countries. PLoS One. 2020 Oct;15(10):e0241031. 10.1371/journal.pone.0241031

Ticona JH, Zaccone VM, McFarlane IM. Community-acquired pneumonia: A focused review. Am J Med Case Rep. 2021 Nov;9 (1):45. 10.12691/ajmcr-9-1-12

Peyrani P, Arnold FW, Bordon J, Furmanek S, Luna CM, Cavallazzi R, et al. Incidence and mortality of adults hospitalized with community-acquired pneumonia according to clinical course. Chest. 2020 Jan;157(1):34–41. 10.1016/j.chest.2019.09.022

Akyil FT, Yalcinsoy M, Hazar A, Cilli A, Celenk B, Kilic O, et al. Prognosis of hospitalized patients with community-acquired pneumonia. Pulmonology. 2018 May;24(3):164–9. 10.1016/j.rppnen.2017.07.010

Pieralli F, Vannucchi V, De Marzi G, Mancini A, Bacci F, Para O, et al. Performance status and in-hospital mortality of elderly patients with community acquired pneumonia. Intern Emerg Med. 2018 Jun;13(4):501–7. 10.1007/s11739-018-1822-1

Wang HE, Muntner P, Chertow GM, Warnock DG. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35(4):349–55. 10.1159/000337487

Chen D, Yuan H, Cao C, Liu Z, Jiang L, Tan Y, et al. Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community-acquired pneumonia. BMC Pulm Med. 2021 Dec;21:1–7. 10.1186/s12890-021-01511-9

Cheng X, Wu B, Liu Y, Mao H, Xing C. Incidence and diagnosis of acute kidney injury in hospitalized adult patients: A retrospective observational study in a tertiary teaching hospital in Southeast China. BMC Nephrol. 2017 Dec;18(1):1–8. 10.1186/s12882-017-0622-6

Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020 Mar;97(5):824–8. 10.1016/j.kint.2020.03.001

Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020 Aug;383:590–2. 10.1056/NEJMc2011400

Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020 Apr;98 (1):219–27. 10.1016/j.kint.2020.04.003

Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett R, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020 Jul;98(1):209–18. 10.1016/j.kint.2020.05.006

Raina R, Mahajan ZA, Vasistha P, Chakraborty R, Mukunda K, Tibrewal A, et al. Incidence and outcomes of acute kidney injury in COVID-19: Asystematic review. Blood Purif. 2021 Jun. pp. 1–14. 10.1159/000514940

Tian J, Xu Q, Liu S, Mao L, Wang M. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia. Curr Med Res Opin. 2020 Nov;36 (11):1747–52. 10.1080/03007995.2020.1830050

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Apr;382(18):1708–20. 10.1056/NEJMoa2002032

Wunderink RG, Waterer G. Advances in the causes and management of community acquired pneumonia in adults. BMJ. 2017 Jul;358:j2471. 10.1136/bmj.j2471

Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet. 2015 Aug;386:1097–108. 10.1016/S0140-6736(15)60733-4

Rey JR, Caro-Codón J, Rosillo SO, Iniesta ÁM, Castrejón-Castrejón S, Marco-Clement I, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020 Dec;22:2205–15. 10.1002/ejhf.1990

Tomasoni D, Inciardi RM, Lombardi CM, Tedino C, Agostoni P, Ameri P, et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. Eur J Heart Fail. 2020 Dec;22:2238–47. 10.1002/ejhf.2052

Alvarez-Garcia J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, Gupta A, Joshi A, et al. New heart failure diagnoses among patients hospitalized for COVID-19. J Am Coll Cardiol. 2021 May;77:2260–2. 10.1016/j.jacc.2021.03.006

Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, et al. Risk factors for chest infection in acute stroke: A prospective cohort study. Stroke. 2007 Aug;38(8):2284–91. 10.1161/STROKEAHA.106.478156

Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 —Systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020 Aug;29:104949. 10.1016/j.jstrokecerebrovasdis.2020.104949.

Aggarwal G, Lippi G, Henry BM. Cerebrovascular disease is associated with an increased disease severity inpatients with coronavirus disease 2019 (COVID-19): A pooled analysis of published literature. Int J Stroke. 2020 Jun;15:385–9. 10.1177/1747493020921664

Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug; 91:889–91. 10.1136/jnnp-2020-323586

Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S, Lewis A, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020 Aug;29:104984. 10.1016/j.jstrokecerebrovasdis.2020.104984

Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021 Feb;16(2):137–49. 10.1177/1747493020972922

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5): 829–38. 10.1016/j.kint.2020.03.005

Taher A, Alalwan AA, Naser N, Alsegai O, Alaradi A. Acute kidney injury in COVID-19 pneumonia: A single-center experience in Bahrain. Cureus. 2020 Aug;12:e9693. 10.7759/cureus.9693

Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010 Mar;77 (6):527–35. 10.1038/ki.2009.502

Abate SM, Ahmed Ali S, Mantfardo B, Basu B. Rate of intensive care unit admission and outcomes among patients with coronavirus: A systematic review and meta-analysis. PloS One. 2020 Jul;15(7):e0235653. 10.1371/journal.pone.0235653

Cillóniz C, Liapikou A, Martin-Loeches I, García-Vidal C, Gabarrús A, Ceccato A, et al. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia. PloS One. 2018 Jul;13(7):e0200504. 10.1371/journal.pone.0200504

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420–2. 10.1016/S2213-2600(20)30076-X

Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. Covid-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020 May;153(6):725–33. 10.1093/ajcp/aqaa062.

Akram AR, Singanayagam A, Choudhury G, Mandal P, Chalmers JD, Hill AT. Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia. Chest. 2010 Oct;138(4):825–32. 10.1378/chest.09-3071

Mohamed MM, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, et al. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney 360. 2020 Jul;1(7):614–22. 10.34067/KID.0002652020

Downloads

Download data is not yet available.

Most read articles by the same author(s)